Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Kemp

Showing results (1-10 of 106) with videos related to

Pageof 11
Sort By:
Seminars in Cancer Biology|July 26, 2005
Multistep skin cancer in mice as a model to study the evolution of cancer cellsChristopher J Kemp
Cold Spring Harbor Protocols|October 3, 2015
Animal Models of Chemical Carcinogenesis: Driving Breakthroughs in Cancer Research for 100 YearsChristopher J Kemp
Trends in Cancer|August 29, 2018
Personalized Cancer Models for Target Discovery and Precision MedicineCarla Grandori, Christopher J Kemp
Future Oncology (London, England)|April 9, 2013
Functional genomics to identify unforeseen cancer drug targetsChristopher J Kemp, Carla Grandori
Cell Cycle (Georgetown, Tex.)|December 22, 2017
DNA-PK, ATM, and ATR: PIKKing on p53Amanda K Ashley, Christopher J Kemp
Molecular Cancer Research : MCR|January 4, 2008
Ataxia-telangiectasia mutated is not required for p53 induction and apoptosis in irradiated epithelial tissuesKay E Gurley, Christopher J Kemp
Cancer Research|August 5, 2008
Metastasis suppressor function of tumor necrosis factor-related apoptosis-inducing ligand-R in mice: implications for TRAIL-based therapy in humans?Anne Grosse-Wilde, Christopher J Kemp
Carcinogenesis|September 10, 2005
Tumor suppressor geneticsShannon R Payne, Christopher J Kemp
Toxicologic Pathology|July 10, 2003
p27(Kip1) (Cdkn1b)-deficient mice are susceptible to chemical carcinogenesis and may be a useful model for carcinogen screeningShannon R Payne, Christopher J Kemp
Current Biology : CB|April 23, 2013
Doxorubicin enhances nucleosome turnover around promotersFan Yang, Christopher J Kemp, Steven Henikoff
Pageof 11

Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Seminars in Cancer Biology|July 26, 2005
Multistep skin cancer in mice as a model to study the evolution of cancer cellsChristopher J Kemp
Cold Spring Harbor Protocols|October 3, 2015
Animal Models of Chemical Carcinogenesis: Driving Breakthroughs in Cancer Research for 100 YearsChristopher J Kemp
Trends in Cancer|August 29, 2018
Personalized Cancer Models for Target Discovery and Precision MedicineCarla Grandori, Christopher J Kemp
Future Oncology (London, England)|April 9, 2013
Functional genomics to identify unforeseen cancer drug targetsChristopher J Kemp, Carla Grandori
Cell Cycle (Georgetown, Tex.)|December 22, 2017
DNA-PK, ATM, and ATR: PIKKing on p53Amanda K Ashley, Christopher J Kemp
Molecular Cancer Research : MCR|January 4, 2008
Ataxia-telangiectasia mutated is not required for p53 induction and apoptosis in irradiated epithelial tissuesKay E Gurley, Christopher J Kemp
Cancer Research|August 5, 2008
Metastasis suppressor function of tumor necrosis factor-related apoptosis-inducing ligand-R in mice: implications for TRAIL-based therapy in humans?Anne Grosse-Wilde, Christopher J Kemp
Carcinogenesis|September 10, 2005
Tumor suppressor geneticsShannon R Payne, Christopher J Kemp
Toxicologic Pathology|July 10, 2003
p27(Kip1) (Cdkn1b)-deficient mice are susceptible to chemical carcinogenesis and may be a useful model for carcinogen screeningShannon R Payne, Christopher J Kemp
Current Biology : CB|April 23, 2013
Doxorubicin enhances nucleosome turnover around promotersFan Yang, Christopher J Kemp, Steven Henikoff
Pageof 11